Recombinant Bovine Interleukin-2 and Dry Cow Therapy: Efficacy to Cure and Prevent Intramammary Infections, Safety, and Effect on Gestation (Q74284114)
scientific article published on 01 January 1998
Language:
(P31) (Q13442814)
(P304) 107-115
(P407) (Q1860)
(P433) 1
(P478) 81
(P577) Thursday, January 1, 1998
Thursday, January 1, 1998
(P953) https://doi.org/10.3168/jds.s0022-0302(98)75557-2
https://api.elsevier.com/content/article/PII:S0022030298755572?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0022030298755572?httpAccept=text/plain
https://linkinghub.elsevier.com/retrieve/pii/S0022030298755572
(P1433) (Q2293258)
(P1476) "Recombinant bovine interleukin-2 and dry cow therapy: efficacy to cure and prevent intramammary infections, safety, and effect on gestation" (language: en)
"Recombinant Bovine Interleukin-2 and Dry Cow Therapy: Efficacy to Cure and Prevent Intramammary Infections, Safety, and Effect on Gestation" (language: en)
(P2093) R. J. Erskine
P. C. Bartlett
S. R. Tavernier
L. H. Fowler
R. D. Walker
J. H. Seguin
D. Shuster
(P2860) (Q24630166)
(Q68273687)
(Q57168032)
(Q72553307)
(Q72392606)
(Q45017960)
(Q71922236)
(Q34238385)
(Q67976454)
(Q38673572)
(Q72573328)
(Q40769397)
(Q68815180)
(Q43733202)
(Q68670571)
(Q53719114)
(Q72273290)
(Q67765593)
(Q43712760)
other details
description scientific article published on 01 January 1998

External Links